Promising COVID-19 Drug Is Part of Global Study Being Led by UNC Researchers
Last week’s authorization by the U.S. Food and Drug Administration for emergency use of bamlanivimab feels like a shot in the arm, so to speak, for Dr. David Wohl, a UNC infectious diseases physician and researcher. A monoclonal antibody developed … Read more